Liz Wager: Does the Wakefield et al case mean we should demand public access to raw data?

The latest chapter in the sad saga of the Wakefield et al paper on the MMR vaccine raises some difficult questions about access to individual patient data. It is possible that the apparent discrepancies between the patient records and the publication might have come to light a whole lot sooner, perhaps even before publication, if […]

Read More…

Domhnall MacAuley on a cure for cancer found (again)

If every media report of a cure for cancer were true, we should live forever. But, the media like a headline health story, and we cannot really blame the journalists. It is largely the fault of epidemiologists, according to Joe McLaughlin (International Epidemiology Institute, Maryland USA), who laments the change in culture. He feels that […]

Read More…

Trish Groves on European clinical trials

The calls to cut the red tape that ties up clinical trials in Europe grow louder and louder (see Editor’s choice, It’s time to change how Europe regulates research). Now Europe’s legislators are listening hard, and the red tape is beginning to fray. The medical research regulators (aka “national competent authorities”) in the EU’s 27 […]

Read More…